| Title : Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes patients - Horie_2011_Clin.Ther_33_973 |
| Author(s) : Horie Y , Kanada S , Watada H , Sarashina A , Taniguchi A , Hayashi N , Graefe-Mody EU , Woerle HJ , Dugi KA |
| Ref : Clin Ther , 33 :973 , 2011 |
| Abstract : Horie_2011_Clin.Ther_33_973 |
| ESTHER : Horie_2011_Clin.Ther_33_973 |
| PubMedSearch : Horie_2011_Clin.Ther_33_973 |
| PubMedID: 21723606 |
| Title : Evaluation of the pharmacokinetic interaction between the dipeptidyl peptidase-4 inhibitor linagliptin and pioglitazone in healthy volunteers - Graefe-Mody_2010_Int.J.Clin.Pharmacol.Ther_48_652 |
| Author(s) : Graefe-Mody EU , Jungnik A , Ring A , Woerle HJ , Dugi KA |
| Ref : Int J Clinical Pharmacology & Therapeutics , 48 :652 , 2010 |
| Abstract : Graefe-Mody_2010_Int.J.Clin.Pharmacol.Ther_48_652 |
| ESTHER : Graefe-Mody_2010_Int.J.Clin.Pharmacol.Ther_48_652 |
| PubMedSearch : Graefe-Mody_2010_Int.J.Clin.Pharmacol.Ther_48_652 |
| PubMedID: 20875371 |
| Title : Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients - Heise_2009_Diabetes.Obes.Metab_11_786 |
| Author(s) : Heise T , Graefe-Mody EU , Huttner S , Ring A , Trommeshauser D , Dugi KA |
| Ref : Diabetes Obes Metab , 11 :786 , 2009 |
| Abstract : Heise_2009_Diabetes.Obes.Metab_11_786 |
| ESTHER : Heise_2009_Diabetes.Obes.Metab_11_786 |
| PubMedSearch : Heise_2009_Diabetes.Obes.Metab_11_786 |
| PubMedID: 19476474 |